COVID-19 Coronavirus

COVID-19 Coronavirus Recent News

Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
Money Stolen On Account COVID-19 Relief Fund Fraud is Shocking! US Justice Department Cracks Whip
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
Virios Therapeutics Long COVID Combo Therapy Shows Improvements: Long-COVID Impacts 65M People
Invivyd's COVID-19 Antibody Shows Favorable Safety, Tolerability Profile For Immunocompromised People
Pfizer's COVID-19 Pill Paxlovid Underutilized in Nursing Homes Despite Proven Efficacy
Novavax's COVID-19 Vaccine Gets Complete Approval From European Commission
Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain
Merck, Ridgeback Withdraw COVID-19 Pill European Application Amid Regulatory Hurdles
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
Invivyd Says Investigational Antibody Shows Potential To Prevent Symptomatic COVID-19
Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech
Novavax's New Vaccine Approach Set to Tackle Rising COVID-19 Emerging Variants
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
Why AstraZeneca Shares Are Trading Higher Today?